Arix Bioscience News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.06.19	Arix Bioscience plc: Imara Presents initial Phase 2a data for IMR-687 (PR Newswire)
18.06.19	Arix Bioscience plc: Imara Presents initial Phase 2a data for IMR-687 (PR Newswire)
02.04.19	Arix Bioscience plc: Aura Completes $40 Million Series D Financing (PR Newswire)
02.04.19	Arix Bioscience plc: Aura Completes $40 Million Series D Financing (PR Newswire)
01.04.19	Arix Bioscience plc - Autolus Presents Initial AUTO1 Data at AACR (PR Newswire)
01.04.19	Arix Bioscience plc - Autolus Presents Initial AUTO1 Data at AACR (PR Newswire)
29.03.19	Arix Bioscience plc - Autolus Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019 (PR Newswire)
29.03.19	Arix Bioscience plc - Autolus Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019 (PR Newswire)
18.03.19	Arix Bioscience plc: Arix Co-leads $63 Million Series B Investment Round for Imara (PR Newswire)
18.03.19	Arix Bioscience plc: Arix Co-leads $63 Million Series B Investment Round for Imara (PR Newswire)
19.02.19	Arix Bioscience plc: Autolus Announces Updated Results From CARPALL Trial (PR Newswire)
19.02.19	Arix Bioscience plc: Autolus Announces Updated Results From CARPALL Trial (PR Newswire)
19.02.19	Arix Bioscience plc: Management and Board Changes (PR Newswire)
19.02.19	Arix Bioscience plc: Management and Board Changes (PR Newswire)
28.12.18	Arix Bioscience plc: Harpoon Announces Proposed Public Offering in the United States (PR Newswire)
28.12.18	Arix Bioscience plc: Harpoon Announces Proposed Public Offering in the United States (PR Newswire)
11.12.18	Arix Bioscience plc: Arix Appoints Dr Christian Schetter as Entrepreneur in Residence (EIR) (PR Newswire)
11.12.18	Arix Bioscience plc: Arix Appoints Dr Christian Schetter as Entrepreneur in Residence (EIR) (PR Newswire)
03.12.18	Arix Bioscience plc: Autolus Announces Update on AUTO4 and AUTO5 Programmes (PR Newswire)
03.12.18	Arix Bioscience plc: Autolus Announces Update on AUTO4 and AUTO5 Programmes (PR Newswire)
15.11.18	Arix Bioscience plc: Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for Second LOXL2 Inhibitor Compound (PR Newswire)
15.11.18	Arix Bioscience plc: Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for Second LOXL2 Inhibitor Compound (PR Newswire)
12.11.18	Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round (PR Newswire)
12.11.18	Arix Bioscience plc: Arix Participates in Harpoon $70m Series C Investment Round (PR Newswire)
02.11.18	Autolus Therapeutics to Present New Data at the ASH Annual Meeting (PR Newswire)
02.11.18	Autolus Therapeutics to Present New Data at the ASH Annual Meeting (PR Newswire)
30.10.18	Arix Bioscience plc - Aura Biosciences Reports Positive Phase 1b/2 Clinical Data for AU-011 (PR Newswire)
30.10.18	Arix Bioscience plc - Aura Biosciences Reports Positive Phase 1b/2 Clinical Data for AU-011 (PR Newswire)
25.10.18	Arix Bioscience plc - Arix to Host Oncology KOL Event on October 30, 2018 (PR Newswire)
25.10.18	Arix Bioscience plc - Arix to Host Oncology KOL Event on October 30, 2018 (PR Newswire)
24.10.18	Arix Bioscience plc - LogicBio Announces Closing of Initial Public Offering (PR Newswire)
24.10.18	Arix Bioscience plc - LogicBio Announces Closing of Initial Public Offering (PR Newswire)
11.10.18	Arix Bioscience plc : Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for LOXL2 Inhibitor Compound (PR Newswire)
11.10.18	Arix Bioscience plc : Pharmaxis Releases Positive Results of Phase 1 Clinical Trial for LOXL2 Inhibitor Compound (PR Newswire)
01.10.18	Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio (PR Newswire)
01.10.18	Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio (PR Newswire)
30.07.18	Arix Bioscience plc: Interim Results for the Six Months Ended 30 June 2018 (PR Newswire)
30.07.18	Arix Bioscience plc: Interim Results for the Six Months Ended 30 June 2018 (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swiss Re	132.40	1.73 %	K V
CieFinRichemont	124.80	1.71 %	K V
ABB	51.02	1.47 %	K V
Sika	231.00	1.27 %	K V
Holcim	90.84	1.23 %	K V
Givaudan	3’878.00	-0.08 %	K V
Roche Hldg G	255.30	-0.08 %	K V
Novartis	93.19	-0.09 %	K V
Swisscom	508.00	-0.10 %	K V
Lonza Grp	525.20	-0.23 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Arix Bioscience PLC Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten